BFBIO begins commercial production at Line II

MG News | February 28, 2025 at 09:34 PM GMT+05:00

Add Mettisglobal as a Trusted Source on Google

0:00

February 28, 2025 (MLN): BF Biosciences Limited (PSX: BFBIO) has successfully commissioned its Line II expansion project, with commercial production now underway.

Following the period-end, the company has introduced four new pharmaceutical products: Heprin (Heparin Sodium), Peg-Filgen (Pegylated Filgrastim), Ferium (Ferric Carboxymaltose), and Serenety (Ondansetron).

The company reported strong financial performance, with earnings per share (EPS) rising to Rs2.66 from Rs2.42.

Revenue surged 46.4% to Rs2.7 billion, driven by higher sales and market expansion.

Gross profit increased 67.5% to Rs1bn, despite a 33.4% rise in the cost of goods sold.

Administrative and selling expenses saw significant jumps due to expansion efforts.

Other income grew 66% to Rs52m, supporting earnings, while finance costs rose 18% to Rs92.6m.

Profit before tax climbed 29.4% to Rs322.4m, though higher tax expenses slowed net profit growth.

Copyright Mettis Link News

Related News

PSHL acquires 25.42% stake in Asia Insurance

PSX Closing Bell: A Shade Lower

SCRA balance climbs Rs2bn to nearly Rs30bn

Name	Price/Vol	%Chg/NChg
KSE100	167,089.28 109.91M	-0.21% -352.63
ALLSHR	101,117.40 308.32M	-0.15% -155.10
KSE30	49,841.71 50.59M	-0.28% -142.15
KMI30	240,372.43 78.75M	-0.02% -45.72
KMIALLSHR	65,518.16 188.07M	-0.05% -35.70
BKTi	46,228.77 7.60M	-0.60% -281.04
OGTi	33,974.66 4.20M	-0.27% -91.31

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	82,910.00	83,705.00 81,750.00	960.00 1.17%
BRENT CRUDE	103.89	105.09 102.33	-0.39 -0.37%
RICHARDS BAY COAL MONTHLY	128.50	0.00 0.00	0.75 0.59%
ROTTERDAM COAL MONTHLY	143.40	143.40 143.40	-1.15 -0.80%
USD RBD PALM OLEIN	1,167.50	1,167.50 1,167.50	0.00 0.00%
CRUDE OIL - WTI	91.24	92.17 90.01	-0.25 -0.27%
SUGAR #11 WORLD	20.27	20.44 20.09	0.12 0.60%